Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens

Leukemia. 1999 Aug;13(8):1295-6. doi: 10.1038/sj.leu.2401464.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Expression Regulation, Neoplastic*
  • Histocompatibility Antigens Class I / genetics*
  • Histocompatibility Antigens Class I / immunology
  • Humans
  • Leukemia / genetics*
  • Leukemia / immunology*
  • Neoplasm Proteins / genetics*
  • Nuclear Proteins*
  • Promyelocytic Leukemia Protein
  • Proto-Oncogene Mas
  • Transcription Factors / genetics*
  • Tumor Suppressor Proteins

Substances

  • Histocompatibility Antigens Class I
  • MAS1 protein, human
  • Neoplasm Proteins
  • Nuclear Proteins
  • Promyelocytic Leukemia Protein
  • Proto-Oncogene Mas
  • Transcription Factors
  • Tumor Suppressor Proteins
  • PML protein, human